Tech Company Financing Transactions

Chiasma Funding Round

Chiasma secured a $70 million Series E financing round on 2/27/2015. Investors included 7 Med Health Ventures, Abingworth and Arch Venture Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

460 Totten Pond Rd. 530
Waltham, MA 02451
USA

Phone

(866) 637-9703

Website

www.chiasmapharma.com

Email Address

[email protected]

Overview

Chiasma is focused on improving the lives of patients by developing and ultimately commercializing oral therapies that eliminate the significant limitations and burdens generally associated with therapies that are currently only available as injections.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Raj Kannan

        

Chief Medical Officer

William Ludlam

        

President

Mark Fitzpatrick

        

VP - Client Services

Asi Haviv

        

VP - Finance

Drew Enamait

        

VP - Marketing

Dana Gelbaum

        

VP - Regulatory Affairs

Shoshie Katz

        

Browse more venture capital transactions:

Prev: 2/27/2015: Accela venture capital transaction
Next: 2/27/2015: MediaCore venture capital transaction

Share this article

About Our Venture Capital Transactions Database

Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary